B-CELL MALIGNANCY
Clinical trials for B-CELL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new B-CELL MALIGNANCY trials appear
Sign up with your email to follow new studies for B-CELL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CRISPR Gene-Editing takes on tough blood cancers in new trial
Disease control Recruiting nowThis study tests a new treatment called CTX112 for people with B-cell blood cancers (like lymphoma or leukemia) that have not responded to standard therapy or have returned. CTX112 uses CRISPR gene-editing to create donor T-cells that target and kill cancer cells. The trial will …
Matched conditions: B-CELL MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Jun 17, 2026 03:27 UTC
-
New pill shows promise for Tough-to-Treat blood cancers
Disease control Recruiting nowThis study tests an oral drug called AS-1763 in adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or other B-cell non-Hodgkin lymphomas who have already tried at least two prior treatments. The main goals are to find the safest dose and see how well the drug c…
Matched conditions: B-CELL MALIGNANCY
Phase: PHASE1 • Sponsor: Carna Biosciences, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
New hope for blood cancer patients: experimental drug HRS-3005 enters human trials
Disease control Recruiting nowThis early-stage study tests a new drug, HRS-3005, in 190 adults with B-cell blood cancers that have returned or not responded to prior treatment. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Participants must be in fairly go…
Matched conditions: B-CELL MALIGNANCY
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New drug targets Hard-to-Treat blood cancers in early trial
Disease control Recruiting nowThis study is testing an experimental drug called BGB-16673 for people with certain B-cell blood cancers (like lymphoma and leukemia) that have come back or not responded to other treatments. The drug works by breaking down a protein that helps these cancer cells grow. The trial …
Matched conditions: B-CELL MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC
-
New drug combo aims to tackle tough blood cancers
Disease control Recruiting nowThis study is for people whose B-cell cancers (like certain lymphomas) have come back or not responded to treatment. It tests a new drug called BGB-16673, which breaks down a protein that helps cancer grow, combined with other cancer drugs. The goal is to find safe doses and see …
Matched conditions: B-CELL MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jun 08, 2026 13:11 UTC
-
Protein-Zapping pill shows promise against tough blood cancers
Disease control Recruiting nowThis study tests a new drug, BGB-16673, that destroys a protein cancer cells need to survive. It is for people with certain blood cancers (like lymphoma or leukemia) that have come back or not responded to other treatments. The goal is to find the best dose and see if it shrinks …
Matched conditions: B-CELL MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 02, 2026 11:59 UTC